University of Cincinnati scientists develop radiation therapy delivery approach using engineered bacteria

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers at the University of Cincinnati developed an approach to radionuclide therapy which uses engineered bacteria to target cancer cells without endogenously targetable receptors. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login